Skip to content

13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one

C29H27ClF2N8O2 — CID 123262054

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
SMILESCCn1ncc2cc(Cl)cc(-c3cc(=O)n(C4CCCC(C)C(=O)Nc5cnn(C(F)F)c5-c5ccnc4c5)cn3)c21
InChIInChI=1S/C29H27ClF2N8O2/c1-3-39-26-18(13-35-39)9-19(30)11-20(26)21-12-25(41)38(15-34-21)24-6-4-5-16(2)28(42)37-23-14-36-40(29(31)32)27(23)17-7-8-33-22(24)10-17/h7-16,24,29H,3-6H2,1-2H3,(H,37,42)
InChIKeyPREZLWRDJBSEFS-UHFFFAOYSA-N
MW593.04 g/mol
LogP5.93
Rot. Bonds4

About 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one

13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one (PubChem CID 123262054) has the molecular formula C29H27ClF2N8O2 and a molecular weight of 593.04 g/mol. Its IUPAC name is 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one.

Molecular Properties

Compound Name13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
PubChem CID123262054
Molecular FormulaC29H27ClF2N8O2
Molecular Weight593.04 g/mol
Exact Mass592.19
IUPAC Name13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
SMILESCCn1ncc2cc(Cl)cc(-c3cc(=O)n(C4CCCC(C)C(=O)Nc5cnn(C(F)F)c5-c5ccnc4c5)cn3)c21
InChIInChI=1S/C29H27ClF2N8O2/c1-3-39-26-18(13-35-39)9-19(30)11-20(26)21-12-25(41)38(15-34-21)24-6-4-5-16(2)28(42)37-23-14-36-40(29(31)32)27(23)17-7-8-33-22(24)10-17/h7-16,24,29H,3-6H2,1-2H3,(H,37,42)
InChIKeyPREZLWRDJBSEFS-UHFFFAOYSA-N
XLogP5.93
TPSA112.52 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms42
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500593.04
LogP ≤ 55.93
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
The IUPAC name of 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one (CID 123262054) is 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one.
What is the SMILES notation for 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
The canonical SMILES for 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one is CCn1ncc2cc(Cl)cc(-c3cc(=O)n(C4CCCC(C)C(=O)Nc5cnn(C(F)F)c5-c5ccnc4c5)cn3)c21.
What is the InChIKey of 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
The InChIKey is PREZLWRDJBSEFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H27ClF2N8O2/c1-3-39-26-18(13-35-39)9-19(30)11-20(26)21-12-25(41)38(15-34-21)24-6-4-5-16(2)28(42)37-23-14-36-40(29(31)32)27(23)17-7-8-33-22(24)10-17/h7-16,24,29H,3-6H2,1-2H3,(H,37,42).
What are the key properties of 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one?
13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one has a molecular weight of 593.04 g/mol, XLogP of 5.93, 4 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 13-[4-(5-chloro-1-ethylindazol-7-yl)-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one is sourced from PubChem (CID 123262054), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.